Perspective: Testing failures.
- Published in:
- Nature, 2012, v. 485, n. 7398, p. S17, doi. 10.1038/485S17a
- By:
- Publication type:
- Article
Works matching DE "MACROGENICS Inc."
Results: 7
1
2
Combo antibody efforts up, despite regulatory uncertainties.
- Published in:
- Nature Medicine, 2011, v. 17, n. 8, p. 907, doi. 10.1038/nm0811-907
- By:
- Publication type:
- Article
3
Takeda's second bet on DARTs.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 11, p. 1070, doi. 10.1038/nbt1114-1070a
- Publication type:
- Article
4
Gilead widens cancer focus.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 90, doi. 10.1038/nbt0213-90b
- By:
- Publication type:
- Article
5
Boehringer splashes out on bispecific antibody platforms.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 1, p. 5, doi. 10.1038/nbt0111-5
- By:
- Publication type:
- Article
6
People.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 5, p. 521, doi. 10.1038/nbt0502-521
- Publication type:
- Article
7
MacroGenics.
- Published in:
- Nature Biotechnology, 2001, v. 19, p. BE12, doi. 10.1038/89384
- By:
- Publication type:
- Article